Skip to main content
. 2011 Oct 19;23(6):1607–1616. doi: 10.1093/annonc/mdr491

Figure 1.

Figure 1.

Kaplan–Meier plots for (A) overall survival and (B) progression-free survival (PFS) by trial and (C) overall survival and (D) PFS by treatment arm. D, doxorubicin; C, cisplatin; HDMTx, high-dose methotrexate; G-CSF, granulocyte colony-stimulating factor.